Licensing Agreement (Details Textual) - USD ($)			1 Months Ended
	Feb. 08, 2016	Oct. 06, 2015	Apr. 26, 2016	Apr. 30, 2016	Jul. 31, 2015
Payments to Acquire Management Contract Rights	$ 75,000
Stock Issued During Period, Value, New Issues	$ 10,746
Stock Issued During Period, Shares, New Issues	106,385
Common Stock, Par or Stated Value Per Share				$ 0.001	$ 0.001
Aegis Therapeutics, LLC [Member]
Payments to Acquire Management Contract Rights		$ 75,000
Stock Issued During Period, Shares, Other		13,697
Stock Issued During Period, Value, Other		$ 106,152
Stock Issued During Period, Value, New Issues			$ 50,000
Stock Issued During Period, Shares, New Issues			431,500
Licensing Agreement Value			$ 300,000
Percentage of shares issued for Amendment Agreement			50.00%
Percentage of shares To be issued on Average Closing Price			75.00%
License Extension Payment Consideration			$ 150,000
Common Stock, Par or Stated Value Per Share			$ 0.001